ArticleNeoplasia (New York, N.Y.)2026

mTOR inhibition augments antitumor immune effector response by reprogramming the TP53-mutant, immune-cold HNSCC tumor microenvironment.

Priyatosh Nath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.